Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike K who wrote (926)	2/13/2002 7:55:33 PM
From: SemiBull	Read Replies (1) of 3044

Human Genome Has Potential but Needs Products thestreet.com "...Jim Fiore, fund manager at the Greenwich, Conn.-based Life Sciences Group, believes that genomics companies, while currently out of favor, could actually outperform the broader sector this year. But he's staying away from HGS because the company is not keeping up with its peers. Fiore points to Millennium Pharmaceuticals (MLNM:Nasdaq - news - commentary - research - analysis), which like HGS hasn't had much success with its genomics program. But the company has acquired two companies -- Leukosite and Cor Therapeutics -- to gain control of two approved drugs and other late-stage drug prospects. "When I compare HGS to Millennium, their market values are roughly the same, but clearly Millennium is doing much more to fulfill its mission," he says. "HGS has a lot of early stage projects in its pipeline, but nobody cares." Fiore is long Millennium..."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next